Antigen Skin Test Market Analysis – Trends, Growth & Forecast 2022-2032

Antigen Skin Test Market Overview

The global antigen skin test market was valued at around USD 2,027.6 Million at the end of 2021. The market is projected to register a 5.2% CAGR and top a valuation of USD 3,548.63 Million by 2032.

Changing lifestyles and environmental factors are contributing to an increase in allergy disorders prevalence worldwide, as antigen skin tests are the most effective diagnostic method for identifying allergies, this is anticipated to increase demand for them.

Antigen skin testing is a diagnostic technique used to determine the cellular immune capability. The immune systems are mostly being tested against the antigens. The primary indication for an antigen skin test is the detection of immediate or delayed hypersensitivity to endogenous or foreign antigens.

Antigen is injected with a needle into the top layer of skin during the antigen skin test technique. Usually on the forearm, a very small amount is injected. An injection site lump that signals the presence of an antigen and the injection site are labelled.

Skin at the injection site will become red as the immune system begins to respond as a result of the antigen. The capability of the immune system depends on the level of hypersensitivity.

To prevent negative results from other hypersensitivity reactions, such as those from a tuberculosis test, the antigen skin test is used. With viral, fungal, and bacterial antigens to which a healthy person is sensitive, antigen skin testing can evaluate a delayed or cellular kind of hypersensitivity reaction.

Antigen exposure is proven by a positive antigen skin test. The lymphocytes and immunoglobulins are the main causes of the inflammatory reactions at the antigen skin test site.

Attributes	Details
Antigen Skin Test Market Value in 2021	USD 2,027.6 Million
Antigen Skin Test Market Value in 2032	USD 3,548.63 Million
Antigen Skin Test Market CAGR (2022 to 2032)	5.22%

What are the Major Drivers Boosting the Demand for Antigen Skin Test Market?

Companies in the antigen skin test market have recently invested heavily in the development of novel tests in order to take advantage of the untapped market's prospects. Hospital-based laboratories are under pressure to provide more services at a lower cost as a result of healthcare cost containment in the majority of developed markets.

Additionally, the prevalence of chronic diseases is increasing, and healthcare facilities are dealing with an ageing population. In accordance with this, antigen skin test producers can seize the chance to offer supplementary services and assistance. All of these elements contribute to the market for antigen skin tests expanding rapidly.

Moreover, with technical improvements, antigen detection methods are changing, which is assisting in a more precise diagnosis of allergies. This is accelerating the global market for antigen skin tests.

Which Region Shows Strong Growth Potential in the Antigen Skin Test Market?

The antigen skin test market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

North America has dominated the regional antigen skin test market due to its well-established healthcare system. Additionally, due to the widespread use of antigen skin tests, the USA in particular is dominant in North America.

Moreover, the Asia Pacific is anticipated to have profitable growth throughout the forecast period, due to the increased incidence of infectious diseases and expanding government efforts to upgrade public health infrastructure in the region. Additionally, the demand for medical products and services has increased as a result of economic growth and a rise in living standards, which will help the market grow throughout the projection period.

Who are the Key Manufacturers in the Antigen Skin Test Market?

Becton, Dickinson and Company (BD), Coris Bioconcept, Nielsen BioSciences Inc., Physicians Total Care Inc., Sanofi Pasteur Limited, Allermed Laboratories, Inc, Par Pharmaceuticals, Era Biology Co. Ltd, ELITech Group, and QIAGEN

Scope of Report

Report Attributes	Details
Growth Rate	CAGR of 5.2% 2022 to 2032
Base Year for Estimation	2021
Historical Data	2012 to 2021
Forecast Period	2022 to 2032
Qualitative Units	Revenue in USD Million, and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered	Test Type, End-User
Region Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa
Key Countries Profiled	USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Spain, Italy, Russia, China, Japan, South Korea, India, Malaysia, Indonesia, Thailand, Australia, New Zealand, GCC Countries, South Africa, North Africa, Turkey
Key Players	Becton, Dickinson and Company (BD); Coris Bioconcept; Nielsen BioSciences Inc.; Physicians Total Care Inc.; Sanofi Pasteur Limited; Allermed Laboratories, Inc; Par Pharmaceuticals; Era Biology Co. Ltd; ELITech Group; QIAGEN
Customization	Available Upon Request

Table of Content

• 1. Executive Summary
• 2. Industry Introduction, including Taxonomy and Market Definition
• 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
• 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
• 5. Pricing Analysis
• 6. Global Market Analysis and Forecast
  • 6.1. Test Type
  • 6.2. End-User
• 7. Global Market Analysis and Forecast, By Test Type
  • 7.1. Bacterial Infections
  • 7.2. Tuberculin Test
  • 7.3. Lepromin Test
  • 7.4. Frei’s
  • 7.5. Others
  • 7.6. Fungal Infection
  • 7.7. Candida test
  • 7.8. Trichophyton
  • 7.9. Coccidioidin test
  • 7.10. Histoplasmin test
  • 7.11. Parasitic Infection
  • 7.12. Montenegro test
• 8. Global Market Analysis and Forecast, By End-User
  • 8.1. Hospitals
  • 8.2. Clinics
  • 8.3. Ambulatory Surgical Centres
• 9. Global Market Analysis and Forecast, By Region
  • 9.1. North America
  • 9.2. Latin America
  • 9.3. Europe
  • 9.4. East Asia
  • 9.5. South Asia
  • 9.6. Oceania
  • 9.7. The Middle East and Africa (MEA)
• 10. North America Sales Analysis and Forecast, by Key Segments and Countries
• 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries
• 12. Europe Sales Analysis and Forecast, by Key Segments and Countries
• 13. East Asia Sales Analysis and Forecast, by Key Segments and Countries
• 14. South Asia Sales Analysis and Forecast, by Key Segments and Countries
• 15. Oceania Sales Analysis and Forecast, by Key Segments and Countries
• 16. The Middle East and Africa (MEA) Sales Analysis and Forecast, by Key Segments and Countries
• 17. Sales Forecast by Test Type and End-User for 30 Countries
• 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
• 19. Company Profile
  • 19.1. Becton
  • 19.2. Dickinson and Company (BD)
  • 19.3. Coris Bioconcept
  • 19.4. Nielsen BioSciences Inc.
  • 19.5. Physicians Total Care Inc.
  • 19.6. Sanofi Pasteur Limited
  • 19.7. Allermed Laboratories, Inc
  • 19.8. Par Pharmaceuticals
  • 19.9. Era Biology Co. Ltd
  • 19.10. ELITech Group; QIAGEN